Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Review Articles

Pathogenesis and management of renal fibrosis induced by unilateral ureteral obstruction: Qi Yan Nan, Shang Guo Piao, Ji Zhe Jin, Byung Ha Chung, Chul Woo Yang, Can Li; Received June 15, 2023 Accepted November 10, 2023 Published online February 6, 2024; [Epub ahead of print]; Full text PubReader ePub PDF

Original Articles

The flavonoid fisetin ameliorates renal fibrosis by inhibiting SMAD3 phosphorylation, oxidative damage, and inflammation in ureteral obstructed kidney in mice: Ha Young Ju, Jongwan Kim, Sang Jun Han; Kidney Res Clin Pract. 2023;42(3):325-339. Published online March 22, 2023; DOI: https://doi.org/10.23876/j.krcp.22.034
Web of Science 3 Cited By 3; Full text PubReader ePub PDF

C-phycocyanin Attenuates Renal Inflammation and Fibrosis in UUO Mice: Sarah Chung, M.D., Jin Young Jeong, Dae Eun Choi, M.D., Ki Ryang Na, M.D., Kang Wook Lee, M.D. and Young Tai Shin, M.D.; Korean J Nephrol. 2010;29(6):687-694.; PDF

Apoptosis of Podocyte and Role of TGF-β1 LAP in Unilateral Ureteral Obstruction in Mice: Won-Dong Lee, M.D. Mi-Seon Kang, M.D. Sun-Woo Kang, M.D. , Yang-Wook Kim, M.D. and Yeong Hoon Kim, M.D.; Korean J Nephrol. 2008;27(3):290-298.; PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

14,860	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,826	C4d Puzzle in ABO-incompatible kidney transplantation
8,286	How should we treat acute kidney injury caused by renal congestion?
13,011	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
35,039	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.